Evidence map›Paper›PMID 39904916›Full record

ArticleImmunogenetics2025

Full-length mRNA sequencing resolves novel variation in 5' UTR length for genes expressed during human CD4 T-cell activation.

Cassandra R Woolley, Julia H Chariker, Eric C Rouchka, Easton E Ford, Elizabeth Hudson, Kamille M Rasche, Caleb S Whitley, Zachary Vanwinkle, Carolyn R Casella, Melissa L Smith and 1 more

Abstract read
In one paragraph

Article in Immunogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cassandra R WoolleyDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0003-2752-1351
Julia H CharikerDepartment of Neuroscience Training, University of Louisville School of Medicine, KY, Louisville, USA.ORCID http://orcid.org/0000-0001-6805-7220
Eric C RouchkaDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0003-3487-6572
Easton E FordDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0001-9812-6741
Elizabeth HudsonDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.
Kamille M RascheDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0002-1083-037X
Caleb S WhitleyDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0003-2142-0111
Zachary VanwinkleDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0009-0005-8823-3670
Carolyn R CasellaDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0009-0008-4268-4216
Melissa L SmithDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0001-7151-3207
Thomas C MitchellDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA. thomas.mitchell@louisville.edu.ORCID http://orcid.org/0000-0002-6493-2232

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
Mechanisms of successful vaccine adjuvantsR01AI127970 · NIAID · UNIVERSITY OF LOUISVILLE · PI MITCHELL, THOMAS C. · 2017 to 2021
$1.9M
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases R01AI127970NIAID NIH HHS R01 AI127970NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20GM103436
6 · The paper itself

Abstract

Isoform sequencing (Iso-Seq) uses long-read technology to produce highly accurate full-length reads of mRNA transcripts. Visualization of individual mRNA molecules can reveal new details of transcript variation within understudied portions of mRNA, such as the 5' untranslated region (UTR). Differential 5' UTRs may contain motifs, upstream open reading frames (uORFs), and secondary structures that can serve to regulate translation or further indicate changes in promoter usage, where transcriptional control may impact protein expression levels. To begin to explore isoform variation during T-cell activation, we generated the first Iso-Seq reference transcriptome of activated human CD4 T cells. Within this dataset, we discovered many novel splice- and end-variant transcripts. Remarkably, one in every eight genes expressed in our dataset was found to have a notable proportion of transcripts with 5' UTR lengthened by over 100 bp compared to the longest corresponding UTR within the Gencode dataset. Among these end-variant transcripts, two novel isoforms were identified for CXCR5, a chemokine receptor associated with T follicular helper cell (Tfh) function and differentiation. When investigated in a model cell system, these lengthened UTR conferred reduced transcript stability and, for one of these isoforms, short uORFs introduced by the added length altered protein expression kinetics. This study highlights instances in which current reference databases are incomplete relative to the information obtained by long-read sequencing of intact mRNA. Iso-Seq is thus a promising approach to better understanding the plasticity of promoter usage, alternative splicing, and UTR sequences that influence RNA stability and translation efficiency.

Indexed as

5' Untranslated RegionsCD4-Positive T-LymphocytesLymphocyte ActivationRNA, MessengerAlternative SplicingGene Expression RegulationHumansOpen Reading FramesPromoter Regions, GeneticSequence Analysis, RNATranscriptome5' Untranslated RegionsRNA, Messenger5′ untranslated region (UTR)Activated CD4 T cellCXCR5Isoform sequencing (Iso-Seq)PacBio

Identifiers

PMID39904916
PMCPMC11794378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.